Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study. J Pak Assoc Dermatol [Internet]. 2024 May 6 [cited 2026 Jul. 26];34(1):191-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2545